技术创新与消费升级
Search documents
孟凡新:怎样理解“人工智能+消费”
Xin Lang Cai Jing· 2026-01-10 04:02
(来源:经济日报) 转自:经济日报 当快速发展的人工智能与我国超大规模消费市场相遇,"人工智能+消费"就成为了政策布局与市场开拓 的关键交汇点。2025年3月印发的《提振消费专项行动方案》明确提出促进"人工智能+消费",开辟高 成长性消费新赛道;国务院印发《关于深入实施"人工智能+"行动的意见》,把"人工智能+"消费提质 作为重点行动;多地提振消费行动中也频频强调推进"人工智能+消费"。那么,人工智能为什么可 以"+"消费?如何推动"人工智能+消费"真正落地见效? 要理解"人工智能+消费",需要回溯技术与消费的本源关系。实际上,技术从来不是孤立的存在,技术 创新、产业创新与消费升级之间始终呈现相互塑造、协同演化的关系。纵观人类经济史,每一次颠覆性 技术革新都会改变原有的生产方式与消费模式,催生出全新的产业形态以及与之适配的消费场景体系。 第一次工业革命以蒸汽机的发明和广泛使用为重要标志,推动了规模化生产和市场地理的扩张,使各国 的地方产品走向更大范围市场。第二次工业革命使人类社会进入电气化时代,家用电器革命性地提升了 家庭生活质量,催生了现代大众消费市场。第三次工业革命以信息技术为核心,互联网打破零售的时空 ...
孟凡新:怎样理解“人工智能+消费”
Jing Ji Ri Bao· 2026-01-08 00:06
当快速发展的人工智能与我国超大规模消费市场相遇,"人工智能+消费"就成为了政策布局与市场 开拓的关键交汇点。2025年3月印发的《提振消费专项行动方案》明确提出促进"人工智能+消费",开辟 高成长性消费新赛道;国务院印发《关于深入实施"人工智能+"行动的意见》,把"人工智能+"消费提质 作为重点行动;多地提振消费行动中也频频强调推进"人工智能+消费"。那么,人工智能为什么可 以"+"消费?如何推动"人工智能+消费"真正落地见效? 要理解"人工智能+消费",需要回溯技术与消费的本源关系。实际上,技术从来不是孤立的存在, 技术创新、产业创新与消费升级之间始终呈现相互塑造、协同演化的关系。纵观人类经济史,每一次颠 覆性技术革新都会改变原有的生产方式与消费模式,催生出全新的产业形态以及与之适配的消费场景体 系。第一次工业革命以蒸汽机的发明和广泛使用为重要标志,推动了规模化生产和市场地理的扩张,使 各国的地方产品走向更大范围市场。第二次工业革命使人类社会进入电气化时代,家用电器革命性地提 升了家庭生活质量,催生了现代大众消费市场。第三次工业革命以信息技术为核心,互联网打破零售的 时空限制,孕育了一批全球消费平台,消费形 ...
医疗ETF(159828)涨超1.4%,板块估值修复或进入新阶段
Sou Hu Cai Jing· 2025-08-19 02:26
Group 1 - The pharmaceutical and biotechnology industry has shown strong performance, with a 25.02% increase since the beginning of 2025, outperforming the CSI 300 index by 18.22 percentage points, ranking 4th in industry performance [1] - The preliminary review of the dual catalog for innovative drugs under basic medical insurance and commercial insurance has been published, with 534 drugs passing the basic medical insurance catalog review and 121 drugs passing the commercial insurance innovative drug catalog review. Antitumor drugs account for 29.2%, anti-infection drugs for 10.5%, and neurological drugs for 10.3% [1] - The sentiment in the innovative drug sector is high, exemplified by the 206.5% increase in the stock price of Silver诺药业 on its first day of trading in Hong Kong, with its core product being the first domestically approved long-acting GLP-1 receptor agonist in China [1] Group 2 - The medical device sub-sector has shown the best performance, with medical research outsourcing increasing by 59.6% since the beginning of the year, while chemical preparations and raw materials have risen by 44% and 42.6% respectively [1] - The overall supply and demand situation in the industry is favorable, driven by policy support and technological innovation, promoting continuous development [1] - The medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies involved in medical devices, medical services, and medical information technology to reflect the overall performance of medical-related listed companies [1]